Epidemiology and Clinical Characteristics of Primary Amebic Meningoencephalitis Caused by Naegleria fowleri: A Global Review.
Naegleria fowleri
free-living ameba
primary amebic meningoencephalitis
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
01 07 2021
01 07 2021
Historique:
received:
06
12
2019
accepted:
29
04
2020
pubmed:
6
5
2020
medline:
8
7
2021
entrez:
6
5
2020
Statut:
ppublish
Résumé
Primary amebic meningoencephalitis (PAM) is a rapidly progressive and often fatal condition caused by the free-living ameba Naegleria fowleri. To estimate the global occurrence, characterize the epidemiology, and describe the clinical features of PAM, we report a series of PAM cases published in the international literature and reported to the Centers for Disease Control and Prevention (CDC). We performed a literature search of PAM case reports published through 2018. Additionally, we included cases reported through the CDC's Free-Living Ameba surveillance or diagnosed via CDC's Free-Living and Intestinal Amebas Laboratory. Cases were classified as confirmed, probable, or suspect on the basis of confirmatory testing, presentation, exposure, and disease course. A total of 381 PAM cases were identified. Seven reported survivors were classified as confirmed. The most commonly reported exposure associated with PAM was swimming/diving, and the most common class of water source was lakes/ponds/reservoirs. Patients were predominantly male (75%), with a median age of 14 years. Confirmed and probable cases were similar in their survival, course of illness, and cerebrospinal fluid (CSF) findings. PAM is a rare but deadly disease with worldwide occurrence. Improved clinician awareness, resulting in earlier diagnosis and treatment, may contribute to increased survival among PAM patients. The case definition of probable used in this study appears to capture cases of PAM, as evidenced by similarities in outcomes, clinical course, and CSF profile to confirmed cases. In the absence of confirmatory testing, clinicians could use this case definition to identify cases of PAM.
Sections du résumé
BACKGROUND
Primary amebic meningoencephalitis (PAM) is a rapidly progressive and often fatal condition caused by the free-living ameba Naegleria fowleri. To estimate the global occurrence, characterize the epidemiology, and describe the clinical features of PAM, we report a series of PAM cases published in the international literature and reported to the Centers for Disease Control and Prevention (CDC).
METHODS
We performed a literature search of PAM case reports published through 2018. Additionally, we included cases reported through the CDC's Free-Living Ameba surveillance or diagnosed via CDC's Free-Living and Intestinal Amebas Laboratory. Cases were classified as confirmed, probable, or suspect on the basis of confirmatory testing, presentation, exposure, and disease course.
RESULTS
A total of 381 PAM cases were identified. Seven reported survivors were classified as confirmed. The most commonly reported exposure associated with PAM was swimming/diving, and the most common class of water source was lakes/ponds/reservoirs. Patients were predominantly male (75%), with a median age of 14 years. Confirmed and probable cases were similar in their survival, course of illness, and cerebrospinal fluid (CSF) findings.
CONCLUSIONS
PAM is a rare but deadly disease with worldwide occurrence. Improved clinician awareness, resulting in earlier diagnosis and treatment, may contribute to increased survival among PAM patients. The case definition of probable used in this study appears to capture cases of PAM, as evidenced by similarities in outcomes, clinical course, and CSF profile to confirmed cases. In the absence of confirmatory testing, clinicians could use this case definition to identify cases of PAM.
Identifiants
pubmed: 32369575
pii: 5830738
doi: 10.1093/cid/ciaa520
pmc: PMC8739754
mid: NIHMS1724410
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e19-e27Subventions
Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States
Informations de copyright
Published by Oxford University Press for the Infectious Diseases Society of America 2020.
Références
J Med Assoc Thai. 1988 Oct;71(10):581-6
pubmed: 3249167
Am J Trop Med Hyg. 2017 Nov;97(5):1600-1602
pubmed: 29016297
Med Trop (Mars). 1981 Nov-Dec;41(6):675-6
pubmed: 7339426
N Engl J Med. 1982 Feb 11;306(6):346-8
pubmed: 7054710
Emerg Infect Dis. 2018 Jan;24(1):162-164
pubmed: 29260676
Annu Rev Microbiol. 1982;36:101-23
pubmed: 6756287
Parasite Immunol. 2004 Jun-Jul;26(6-7):247-64
pubmed: 15541029
J Indian Med Assoc. 1972 Jan 1;58(1):13-4
pubmed: 5021267
Clin Infect Dis. 2016 Mar 15;62(6):774-6
pubmed: 26679626
J Pediatric Infect Dis Soc. 2015 Dec;4(4):e68-75
pubmed: 26582886
J Clin Microbiol. 1987 Sep;25(9):1629-34
pubmed: 3308948
MMWR Morb Mortal Wkly Rep. 2013 Nov 15;62(45):903
pubmed: 24226628
IDCases. 2019 Mar 12;15:e00524
pubmed: 30937287
PLoS Negl Trop Dis. 2014 Aug 14;8(8):e3017
pubmed: 25121759
Arch Med Res. 2005 Jan-Feb;36(1):83-6
pubmed: 15900627
BMC Infect Dis. 2018 Jul 28;18(1):349
pubmed: 30055569
Pediatrics. 2015 Mar;135(3):e744-8
pubmed: 25667249
Lancet. 1972 Aug 19;2(7773):379
pubmed: 4114746
Emerg Infect Dis. 2004 Oct;10(10):1835-7
pubmed: 15504272
Rev Infect Dis. 1990 May-Jun;12(3):490-513
pubmed: 2193354
Trans R Soc Trop Med Hyg. 1983;77(3):372-7
pubmed: 6623596
J Clin Microbiol. 2006 Oct;44(10):3589-95
pubmed: 17021087
Br Med J. 1965 Sep 25;2(5464):740-2
pubmed: 5825411
Parasitol Res. 2020 Jan;119(1):339-344
pubmed: 31734864
Folia Parasitol (Praha). 1980;27(1):11-7
pubmed: 7364343
Clin Infect Dis. 2012 Nov;55(9):e79-85
pubmed: 22919000
Curr Opin Infect Dis. 2010 Dec;23(6):590-4
pubmed: 20802332
FEMS Immunol Med Microbiol. 2007 Jun;50(1):1-26
pubmed: 17428307
Epidemiol Infect. 2010 Jul;138(7):968-75
pubmed: 19845995
Infect Genet Evol. 2011 Oct;11(7):1520-8
pubmed: 21843657
Clin Infect Dis. 2012 Mar;54(6):805-9
pubmed: 22238170